High doses of intravenous protamine cause generalized vascular permeability changes in brain and other organs, and concomitant hypoproteinemia. The present investigations test the hypothesis that protamine has a dual action of both binding serum proteins and of undergoing absorptive-mediated transcytosis through microvascular endothelial barriers. Binding of albumin to protamine was demonstrated using equilibrium dialysis, and protamine was shown to selectively augment the uptake of albumin, but not sucrose, in isolated bovine or human brain capillaries. In contrast, the anionic macromolecule, dextran sulfate, resulted in an increased capillary uptake of both albumin and sucrose in vitro. The selective effects of protamine on albumin transport were also documented in vivo using an external organ technique; the intravenous injection of 1.5 mg/kg protamine resulted in a marked and selective influx of albumin into brain, heart, kidney, lung, and liver, and the increased albumin transport exceeded the increased sucrose uptake in some organs by an order of magnitude. The transcytosis of protamine through the cerebral microvascular barrier was documented with an internal carotid artery perfusion technique. In summary, these studies provide evidence for protamine-mediated vectorial transport of albumin through microvascular barriers in brain and other organs.
W M Pardridge, J L Buciak, Y S Kang, R J Boado
Title and authors | Publication | Year |
---|---|---|
Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool
MI Sajid, M Moazzam, R Stueber, SE Park, Y Cho, N ul Ain Malik, RK Tiwari |
Peptides | 2021 |
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies
J Karlsson, KM Luly, SY Tzeng, JJ Green |
Advanced Drug Delivery Reviews | 2021 |
Biotherapeutic effect of cell-penetrating peptides against microbial agents: a review
IZ Sadiq, A Muhammad, SB Mada, B Ibrahim, UA Umar |
Tissue Barriers | 2021 |
Biotherapeutic effect of cell-penetrating peptides against microbial agents: a review.
Sadiq IZ, Muhammad A, Mada SB, Ibrahim B, Umar UA |
Tissue Barriers | 2021 |
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies.
Karlsson J, Luly KM, Tzeng SY, Green JJ |
Advanced Drug Delivery Reviews | 2021 |